OVID - Ovid Therapeutics GAAP EPS of -$0.16 beats by $0.02 March, 13 2023 08:20 AM Ovid Therapeutics Inc. 2023-03-13 08:20:27 ET Ovid Therapeutics press release ( NASDAQ: OVID ): Q4 GAAP EPS of -$0.16 beats by $0.02 . Cash, cash equivalents and marketable securities as of December 31, 2022 totaled $129.0 million. For further details see: Ovid Therapeutics GAAP EPS of -$0.16 beats by $0.02